Dataset Information

RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.

ABSTRACT:

Introduction

The receptor activator nuclear factor-kappaB ligand (RANKL) diffuses from articular cartilage to subchondral bone. However, the role of chondrocyte-synthesized RANKL in rheumatoid arthritis-associated juxta-articular bone loss has not yet been explored. This study aimed to determine whether RANKL produced by chondrocytes induces osteoclastogenesis and juxta-articular bone loss associated with chronic arthritis.

Methods

Chronic antigen-induced arthritis (AIA) was induced in New Zealand (NZ) rabbits. Osteoarthritis (OA) and control groups were simultaneously studied. Dual X-ray absorptiometry of subchondral knee bone was performed before sacrifice. Histological analysis and protein expression of RANKL and osteoprotegerin (OPG) were evaluated in joint tissues. Co-cultures of human OA articular chondrocytes with peripheral blood mononuclear cells (PBMCs) from healthy donors were stimulated with macrophage-colony stimulating factor (M-CSF) and prostaglandin E2 (PGE2), then further stained with tartrate-resistant acid phosphatase.

Results

Subchondral bone loss was confirmed in AIA rabbits when compared with controls. The expression of RANKL, OPG and RANKL/OPG ratio in cartilage were increased in AIA compared to control animals, although this pattern was not seen in synovium. Furthermore, RANKL expression and RANKL/OPG ratio were inversely related to subchondral bone mineral density. RANKL expression was observed throughout all cartilage zones of rabbits and was specially increased in the calcified cartilage of AIA animals. Co-cultures demonstrated that PGE2-stimulated human chondrocytes, which produce RANKL, also induce osteoclasts differentiation from PBMCs.

Conclusions

Chondrocyte-synthesized RANKL may contribute to the development of juxta-articular osteoporosis associated with chronic arthritis, by enhancing osteoclastogenesis. These results point out a new mechanism of bone loss in patients with rheumatoid arthritis.

SUBMITTER: Martinez-Calatrava MJ

PROVIDER: S-EPMC3446534 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.

Martínez-Calatrava Maria J MJ Prieto-Potín Ivan I Roman-Blas Jorge A JA Tardio Lidia L Largo Raquel R Herrero-Beaumont Gabriel G

Arthritis research & therapy 20120618 3

<h4>Introduction</h4>The receptor activator nuclear factor-kappaB ligand (RANKL) diffuses from articular cartilage to subchondral bone. However, the role of chondrocyte-synthesized RANKL in rheumatoid arthritis-associated juxta-articular bone loss has not yet been explored. This study aimed to determine whether RANKL produced by chondrocytes induces osteoclastogenesis and juxta-articular bone loss associated with chronic arthritis.<h4>Methods</h4>Chronic antigen-induced arthritis (AIA) was induc ...[more]

PMID: 22709525

Similar Datasets

Project description:Chondroblastoma is a rare benign cartilaginous lesion located mostly in the epiphyses of the long bones. The most common locations are the proximal tibia or femur, distal femur, and proximal humerus. Open curettage and bone grafting constitute the mainstay treatment for this condition. Few reports have documented the use of arthroscopy in tumor surgery owing to the problem of inadequate removal and the difficulty of bone graft delivery to the tumor cavity. The bazooka technique should solve these 2 main problems. In this article, arthroscopic curettage and grafting are described for the treatment of juxta-articular proximal humeral chondroblastoma to lessen postoperative pain and thus enable early mobilization and a quicker rehabilitation in skeletally immature patients. Technique Video Video 1 The bazooka procedure is performed with the patient in the modified beach-chair position. In this case, the patient had proximal humeral chondroblastoma in the right shoulder. The procedure starts with the use of a posterior portal as the viewing portal. A spinal needle is then used to locate the lesion from anterior. An anterior rotator interval portal is established, with care taken to avoid damage to the biceps tendon and subscapularis. A small periosteal elevator is used to raise a cartilage flap from the roof of the lesion, with care taken to avoid damage to uninvolved cartilage. A small curette is used to penetrate the roof and make the orifice to the lesion. A 4.5-mm shaver is used through the anterior portal to debride tumor tissue. A high-speed burr is used under fluoroscopic guidance to penetrate the walls of the lesion until healthy subchondral bone is reached for later graft incorporation. The scope is shifted to the anterior portal to visualize the lesion from anterior and ensure complete tumor excision. The bazooka is then prepared. A wide-diameter transparent cannula is obtained and dislodged. The trocar is blunted for later graft impaction. A bone graft is taken from the patient's iliac bone and fashioned into small chips. The bazooka is loaded with bone graft to two-thirds of its length. The cannula is inserted from the anterior portal and centered over the orifice of the defect. The bone graft is loaded into the bazooka. Bone graft impaction is performed using the blunted cannula trocar. This step is repeated until complete sealing of the defect is achieved.

Project description:Radiation therapy is an integral part of treatment for cancer patients; however, major side effects of this modality include aberrant bone remodeling and bone loss. Ionizing radiation (IR) is a major external factor that contributes to a significant increase in oxidative stress such as reactive oxygen species (ROS), has been implicated in osteoporotic phenotypes, and has been implicated in osteoporotic phenotypes, bone loss, and fracture risk. One of the major cellular defenses against heightened oxidative stress is mediated by nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a master transcription factor that regulates induction of antioxidant gene expression and phase II antioxidant enzymes. Our objective was to test the hypothesis that loss of functional Nrf2 increases radiation-induced bone loss. We irradiated (single dose, 20Gy) the hindlegs of age- and sex-matched Nrf2(+/+) and Nrf2(-/-) mice. After 1 month, microCT analysis and histology revealed a drastic overall decrease in the bone volume after irradiation of mice lacking Nrf2. Although radiation exposure led to bone loss in mice with intact Nrf2, it was dramatically enhanced by loss of Nrf2. Furthermore, in the absence of Nrf2, a decrease in osteoblast mineralization was noted in calvarial osteoblasts compared with wild-type controls, and treatment with a common antioxidant, N-acetyl-l-cysteine (NAC), was able to rescue the mineralization. As expected, we observed a higher number of osteoclasts in Nrf2(-/-) mice compared to Nrf2(+/+) mice, and after irradiation, the trend remained the same. RT-PCR analysis of calvarial osteoblasts revealed that in the absence of Nrf2, the expression of RANKL was increased after irradiation. Interestingly, RANKL expression was suppressed when the calvarial osteoblasts were treated with NAC before IR exposure. Taken together, our data suggest that loss of Nrf2 leads to heightened oxidative stress and increased susceptibility to radiation-induced bone loss.

Dataset Information

RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.

Introduction

Methods

Results

Conclusions

Publications

RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets